This is supported by evidence from a mouse model of Alzheimer's disease (Transgenic human APP mouse), where increased PLA2 activity and AA levels were observed (Sanchez-Mejia et al., 2008). The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.